This transaction was executed in multiple trades at prices ranging from $15.42 USD to $15.785 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $15.395 USD to $15.785 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 156,983 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

/s/ Michael Pisetsky, Attorney-in-Fact for Anshul Maheshwari


Represents shares automatically sold solely to satisfy tax withholding obligations of reporting person on vesting of restricted stock. Proceeds from the sale were submitted to the Internal Revenue Service.

Includes shares purchased under the Commvault Employee Stock Purchase Plan on August 14, 2025.

The sale reported in this Form 4 was effected pursuant to an existing Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.14 and $177.04, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.21 and $178.18, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.22 and $179.05, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.28 and $176.25, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.33 and $177.17 inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.87 and $178.77 inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

/s/ Danielle Abrahamsen, Attorney-in-Fact


Represents performance-based restricted stock units previously granted to the Reporting Person by the Issuer on August 2, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee effective on August 18, 2025, resulting in the immediate vesting of the restricted stock units as to 2,732 shares of Common Stock.

Includes (i) 4,620 shares of restricted stock units that vest in three substantially equal installments on each of March 17, 2026, March 17, 2027 and March 17, 2028, (ii) 2,800 shares of restricted stock units that vest in two substantially equal installments on each of March 20, 2026 and March 20, 2027 and (iii) 934 shares of restricted stock that vest on March 7, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Includes 386 shares of Common Stock purchased under the Amended and Restated Willdan Group, Inc. 2006 Employee Stock Purchase Plan on June 30, 2025.

Represents shares of the Issuer's Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of the performance-based restricted stock units referenced in footnote (1).

/s/ Creighton K. Early, Attorney-in-fact for Micah Chen


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Includes the grant of 1250 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock.

Includes the grant of 250 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 100 restricted stock units remain unvested.

Includes the grant of 750 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 450 restricted stock units remain unvested.

Includes the grant of 800 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 640 restricted stock units remain unvested.

Includes the grant of 1391 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2026, and that may be settled only in shares of the Issuer's common stock.

The options vest and become exercisable in five equal installments beginning May 23, 2017

The options vest and become exercisable in five equal installments beginning May 12, 2018.

The options vest and become exercisable in five equal installments beginning May 23, 2019.

The options vest and become exercisable in five equal installments beginning May 23, 2020

The options vest and become exercisable in five equal installments beginning May 12, 2022.

The options vest and become exercisable in five equal installments beginning March 12, 2021.

The options vest and become exercisable in five equal installments beginning January 12, 2017


The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

This transaction was executed in multiple trades at prices ranging from $15.52 USD to $15.83 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $15.50 USD to $15.80 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $15.50 USD to $15.83 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $15.50 USD to $15.81 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 396,297 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Shares held by The David & Laura Joint Rev Tr.

/s/ Michael A. Pisetsky, Attorney-in-Fact for Laura A. Francis


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.299 to $5.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.02 to $5.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The Reporting Person has control and voting power over the securities held by Buckley Coble Family Ventures LP.


Labe James

C/O TRIPLEPOINT VENTURE GROWTH BDC CORP.

Held in children's custodian trust accounts

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all or any of the reported shares for purposes of Section 16 or for any other purpose.

Includes shares of common stock received pursuant to TPVG's dividend reinvestment plan.


Represents the weighted average price of shares sold at prices that ranged from $69.0000 to $69.8600.

Represents the weighted average price of shares sold at prices that ranged from $70.2400 to $70.3300.

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted on March 7, 2025.


The Reporting Person undertakes to provide to NewLake Capital Partners, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote in this Form 4. The reported prices above reflect the weighted average, rounded to the nearest hundredth. On August 19, 2025, the highest price at which shares were sold was $14.17, and the lowest price at which shares were sold was $14.00. On August 20, 2025, the highest price at which shares were sold was $13.87, and the lowest price at which shares were sold was $13.82. On August 18, 2025, the Reporting Person filed with the Securities and Exchange Commission a Form 144 covering the sale of the Issuer's common stock reported in Table I.


Date of grant, with first vesting occurring on August 19, 2026. One-third of the total shares vest on that date and an additional one-third vest on each of the next two anniversaries thereafter.


Common Stock

Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") Common Stock. This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date.

The sales reported on this Form 4 represent shares of Common Stock sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

This transaction was executed in multiple trades at prices ranging from $7.89 to $8.10. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This number reflects the aggregate amount of Common Stock held by the reporting person.

The balance reflects an indirect interest in 4,625 shares owned by the spouse of the reporting person, whom the reporting person recently married, which were inadvertently omitted from prior filings.

In connection with the spin-off of Fortrea by Laboratory Corporation of America Holdings ("Labcorp"), RSUs granted by Labcorp were converted into time-vesting RSUs of Fortrea pursuant to the terms of the Employee Matters Agreement. These RSUs vested on August 17, 2025.

This number reflects the aggregate number of RSUs held by the reporting person.

/s/ James Stillman Hanson, Attorney-in-Fact for Mark A. Morais


Kayne Anderson Energy Infrastructure Fund, Inc.

Baker James C

C/O KAYNE ANDERSON CAPITAL ADVISORS, L.P


Common Stock

Common Stock

The restricted stock units vested in full on August 18, 2025. Vested shares were delivered to the reporting person upon vest.

Each restricted stock unit represents a contingent right to receive one share of Microchip Technology Incorporated common stock.

The Restricted Stock Units shall vest in full on the earlier of (i) one day prior to the next annual meeting of stockholders or (ii) one year from the date of grant.  All vesting of the Restricted Stock Unit Grant is contingent upon the Non-Employee Director maintaining continued status as a Non-Employee Director through the applicable vesting date.


Common Stock

/s/ James Stillman Hanson, Attorney-in-Fact for Jill G. McConnell


Common Stock

Common Stock

he price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.10, inclusive. The Reporting Person undertakes to provide Lindblad Expeditions Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Stock option granted under the 2021 Long Term Incentive Plan pursuant to his employment agreement.

/s/ John J. Wolfel, Attorney-in-Fact for Benjamin Bressler


The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 13, 2025.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.04 to $255.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.04 to $256.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.04 to $256.65 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.20 to $255.19 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.22 to $256.21 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.23 to $257.17 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.24 to $258.23 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.24 to $258.43 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.82 to $259.81 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.82 to $260.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.82 to $261.42 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder ("Section 16"), each Reporting Person may be deemed to be a director-by-deputization by virtue of the fact that each of Timotheus Hoettges, Chief Executive Officer of DT, Dr. Christian P. Illek, Board Member for Finance of DT, Raphael Kubler, Senior Vice President of the Corporate Operating Office of DT and Managing Director of Deutsche Telekom Holding B.V., Thorsten Langheim, Board Member for USA and Group Development of DT, and Dominique Leroy, Board Member for Europe of DT, serve on the board of directors of the Issuer. In addition, Each of T-Mobile Global Zwischenholding GmbH, T-Mobile Global Holding GmbH and Deutsche Telekom Holding B.V. are wholly-owned subsidiaries of DT. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Deutsche Telekom disclaims beneficial ownership in any Common Stock held by Project 6 or Project 9 if such Common Stock is not subject to the Proxy Agreement.


Common Stock

Common Stock

Of the 2,326 shares held, 2,280 shares were held by The Peng Family Revocable Trust, and 46 shares were held by an IRA in the owner's name.

The restricted stock units vested in full on August 18, 2025. Vested shares were delivered to the reporting person upon vest.

Each restricted stock unit represents a contingent right to receive one share of Microchip Technology Incorporated common stock.

The Restricted Stock Units shall vest in full on the earlier of (i) one day prior to the next annual meeting of stockholders or (ii) one year from the date of grant.  All vesting of the Restricted Stock Unit Grant is contingent upon the Non-Employee Director maintaining continued status as a Non-Employee Director through the applicable vesting date.


Common Stock

Common Stock


Upon the termination of a grantor retained annuity trust on August 18, 2025, a total of 32,258 shares of common stock were transferred to two irrevocable trusts for the benefit of each of the reporting person's adult children where a member of the reporting person's immediate family serves as trustee.  These transfers are exempt from Section 16(b) pursuant to Rule 16b-5.

Reflects transfers of shares of common stock between the reporting person and a number of grantor retained annuity trusts, which are exempt from Section 16 pursuant to Rule 16a-13.

Evgeniya Berezkina, Attorney-in-fact for Hans Erik Vestberg


The Michael J. O'Neil, Jr. and Katrina E. Nappa 2018 Trust, dtd 12/5/2018


The 2018 Jane and Michael Hoffman Descendants Trust

The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.


Represents the number of shares withheld by the Company upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Stride common stock on the most recent prior market day.

The sales reported in these transactions were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 2, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.68 to $163.91, inclusive. The reporting person undertakes to provide to Stride, Inc., any security holder of Stride, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Non-qualified Stock Option (Right to Buy)

Common Stock

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $243.5400 to $244.5348 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $244.5728 to $245.4730 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $245.5700 to $246.0100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $246.5709 to $247.5600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Shares held in the Marc Benioff Fund LLC (the "Fund").  Fund interests are held in the reporting person's name or in trust.

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff


Represents shares sold as part of a sell-to-cover program to satisfy tax withholding obligations upon the vesting of stock awards.

Represents the per share price attributed to sales of shares on behalf of all participants under the sell-to-cover program on the transaction date indicated.


This transaction was executed pursuant to a trading plan entered into by the reporting person on May  13,  2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.41 to $215.56. Information regarding the number of shares sold at each price will be provided upon request.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.7501 to $75.7750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Total shares beneficially owned includes 2,930 shares of which Mr. Ahola has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

Held by the Aaron Ahola Revocable Trust for which the Reporting Person serves as trustee.

As of August 19, 2025.

/s/ Thomas M. Lair, as power of attorney


The shares were sold in multiple trades at prices ranging from $16.01 to $16.43. The price reported above reflects the weighted average sales price.

The shares were sold in multiple trades at prices ranging from $15.90 to $16.19. The price reported above reflects the weighted average sales price.

The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.


Common Stock

Common Stock

The stock options are fully vested.


Represents the number of shares withheld by the Company upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Stride common stock on the most recent prior market day.


Represents the aggregate number of shares sold by the Reporting Person as a result of a mandatory sale to cover taxes and fees due upon the release and settlement of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $4.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Includes 750 shares purchased pursuant to the 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of February 1, 2025 to July 31, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 31, 2025.


Shares held by an Angela L. Muhleisen GRAT dated 6/10/2020. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by a separate Angela L. Muhleisen GRAT dated 6/10/2020. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by an Angela L. Muhleisen GRAT dated 11/29/2022. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by a separate Angela L. Muhleisen GRAT dated 11/29/2022. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by a Dynasty Trust established by Ms. Muhleisen and her deceased spouse, Dan D. Muhleisen, in 2012, of which the adult daughter of Ms. and Mr. Muhleisen is the initial beneficiary. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by a Dynasty Trust established by Ms. and Mr. Muhleisen in 2012, of which the adult son of Ms. and Mr. Muhleisen is the initial beneficiary. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by a Dynasty Trust established by Ms. Muhleisen in 2020, of which the adult daughter and the adult son of Ms. and Mr. Muhleisen are the initial beneficiaries. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by a Dynasty Trust established by Mr. Muhleisen in 2020, of which the adult daughter and the adult son of Ms. and Mr. Muhleisen are the initial beneficiaries. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by the Dan D. Muhleisen 2020 Post-Annuity GRAT, of which the adult daughter of Ms. and Mr. Muhleisen is the beneficiary. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

Shares held by the Dan D. Muhleisen 2020 Post-Annuity GRAT, of which the adult son of Ms. and Mr. Muhleisen is the beneficiary. Ms. Muhleisen continues to report beneficial ownership of all the shares held by the trust, but disclaims beneficial ownership of the shares held by the trust except to the extent of her pecuniary interest therein.

/s/ Audra Hoffschneider, Attorney-in-Fact for Angela L. Muhleisen


Open market purchases of shares in accordance with Issuer's trading policies.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.375 to $2.60 per share. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.


Common Stock, $0.0001 par value per share

By Forge Trust Co CFBO Kelly Rodriques Roth IRA

The sales reported on this Form 4 represent shares of Common Stock sold by the Reporting Person to cover tax obligations in connection with the vesting of restricted stock units.


Represents the aggregate number of shares sold by the Reporting Person as a result of a mandatory sale to cover taxes and fees due upon the release and settlement of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $4.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.


Common Stock

These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on February 19, 2025 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Includes unvested RSUs.

The price reported in Column 4 is a weighted average price. These shares of common stock, par value $0.01 per share ("Common Stock") of Waystar Holding Corp. (the "Issuer") were sold in multiple transactions ranging from $34.73 to $35.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price in the range set forth in this footnote.

These options are currently vested.

/s/ Gregory R. Packer, as Attorney-in-Fact


The sales reported occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2024.

The price reported is the weighted average price of multiple transactions ranging from $105.13 to $106.115.  The reporting person hereby undertakes to provide upon request to the SEC, the Issuer or a security holder of the Issuer the number of Common Stock and the prices at which the transactions were effected.

The price reported is the weighted average price of multiple transactions ranging from $106.15 to $106.96.  The reporting person hereby undertakes to provide upon request to the SEC, the Issuer or a security holder of the Issuer the number of Common Stock and the prices at which the transactions were effected.

The reported amount consists of 36,299 restricted stock units and 541,560 shares of Common Stock.  The restricted stock units are to be settled in an equal number of shares of Common Stock upon vesting.

/s/ Derek W. Stark, attorney-in-fact for Mr. Spector


Common units representing limited partner interests

The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $11.915 to $12.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $11.94 to $12.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote.

/s/ Steve Putman, attorney-in-fact for Thomas L. Carter, Jr.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.42 to $40.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Mr. Marchetti has sole power to vote and dispose of these Shares, but disclaims beneficial ownership of these Shares except to the extent of any pecuniary interest therein.

Represents Shares held directly by BG Lineage Holdings, LLC ("BGLH") and indirectly by Mr. Marchetti. BGLH is indirectly managed by Bay Grove Capital Group LLC, which is managed by a committee comprised of Mr. Marchetti and Adam Forste, who share voting and investment power over these Shares. Mr. Marchetti disclaims beneficial ownership over the Shares held by BGLH, except to the extent of any pecuniary interest therein.

/s/ Kristina Hentschel, as Attorney-in-Fact, for Kevin Patrick Marchetti


The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.09 to $12.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.


Ordinary Shares

Represents Ordinary Shares vesting upon exercise of restricted stock units ("RSUs") awarded under the Company's 2025 Omnibus Equity Incentive Plan (the "Plan").

These shares were valued at $3.15 per share the closing market price on July 25, 2025.

These RSUs were issued under the Plan in an exempt transaction pursuant to Rule 16b-3 under the Securities Exchange Act of 1934.


Common Stock

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1399.40 - $1400.01. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1400.57 - $1401.43. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1402.98 - $1403.88. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1404.00 - $1404.97. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1405.01 - $1406.00. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1406.08 - $1407.00. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1410.21 - $1410.31. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1411.27 - $1411.60. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.


Common Stock

These shares are restricted stock units with restrictions that lapse over a four-year period with respect to 25% of these shares per year, starting on August 18, 2026 and thereafter on August 18, 2027, August 18, 2028 and August 18, 2029.

Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.

The option vests in four equal annual installments beginning on August 18, 2026 and thereafter on August 18, 2027, August 18, 2028 and August 18, 2029.

/s/ Joseph Colella, Attorney-In-Fact for David Reeder


These shares were acquired on August 18, 2025 through the Gran Tierra Inc. Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Purchase price of security was transacted in Canadian currency and converted to U.S. currency.


Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs vest 100% as of the last business day preceding the date of the Issuer's next scheduled annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date and acceleration in certain circumstances.

/s/ Philip Reuther, Attorney-in-Fact for Brandi Elizabeth Thomas


Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

Includes 49,687 RSUs.


Represents a grant of performance-based restricted stock under the 2015 Omnibus Incentive Plan that vested on the date the Human Capital and Compensation Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals, which are based on relative total shareholder return, were attained for the performance period of July 3, 2022, to June 28, 2025.

Represents a grant of restricted stock that vests in three equal annual installments beginning on August 20, 2026.


Includes 51,092 RSUs.


These shares were acquired on August 18, 2025 through the Gran Tierra Inc. Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d)
and Rule 16b-3(c).


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.0500 to $169.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.0500 to $170.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.0800 to $171.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5950 to $174.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents a bona fide gift of shares to a non-affiliated entity.

Represents a bona fide gift of shares to a non-affiliated person.

This Form 4/A (this "Amendment") amends and restates in its entirety the original Form 4 filed with the U.S. Securities and Exchange Commission on August 11, 2025 (the "Original Form") to remove the transaction relating to the acquisition of Astera Labs, Inc. common stock ("Common Stock") by GlobalStar Donor Advised Fund ("DAF"), of which the Reporting Person was inadvertently reported due to administrative error as being a trustee. In fact, the Reporting Person has no pecuniary interest in GlobalStar DAF; as such, the 7,500 shares were gifted to and acquired by a non-affiliated entity, as reported in this Amendment.


This transaction was executed in multiple trades at prices ranging from $450.835 to $451.765. The price reported above reflects the weighted average sale price.

This transaction was executed in multiple trades at prices ranging from $451.865 to $452.06. The price reported above reflects the weighted average sale price.

/s/ Joseph W. Clementz, as attorney in fact for James A. Goldman


Includes 60,546 RSUs.


RUSSELL WEINER TRUST AGREEMENT U/A DTD 09/03/2003

The transaction reported represents a gift by the reporting person to a charitable donor-advised fund. The transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Act"), pursuant to Rule 16b-5 of the Act.

/s/ Joseph W. Clementz, as attorney in fact for Russell J. Weiner


Represents shares of common stock withheld to pay Mr. Seth's tax withholding obligations incurred in connection with the vesting of 300,000 restricted stock units, or RSUs, on August 18, 2025. On August 17, 2022, Mr. Seth was granted an award of 300,000 RSUs, in exchange for warrants granted to Mr. Seth on December 17, 2012 for services provided to the Company prior to becoming employed by Actinium. The warrants were in the money since vesting on December 17, 2013. Mr. Seth refrained from exercising the warrants to be aligned with the long-term interests of the Company and stockholders. In November 2018, the Board extended the expiration of Mr. Seth's warrants to February 2022. In February 2022, the Company requested that Mr. Seth not exercise the warrants. In exchange, the Board determined to grant Mr. Seth 300,000 RSUs based on the average fair value of the warrants during their vested life to continue to align Mr. Seth with the long-term interest of the Company and stockholders.


Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Vice President of Finance, Treasurer, Principal Accounting Officer

/s/ Martin Wilson, as attorney-in-fact for John Militello


/s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz


Global GP LLC is purchasing common units for the purpose of satisfying obligations pursuant to awards previously granted to directors and officers under the Global Partners LP Long-Term Incentive Plan ("LTIP"). The reporting person disclaims any pecuniary interest in these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for the purpose of Section 16.

The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $49.89 to $50.94, inclusive. The reporting person undertakes to provide to Global Partners LP, any security holder of Global Partners LP, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $50.28 to $50.94, inclusive. The reporting person undertakes to provide to Global Partners LP, any security holder of Global Partners LP, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.

The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $50.50 to $50.99, inclusive. The reporting person undertakes to provide to Global Partners LP, any security holder of Global Partners LP, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Erin Powers Brennan, Attorney-in-Fact for Global GP LLC


Represents a grant of performance-based restricted stock under the 2015 Omnibus Incentive Plan that vested on the date the Human Capital and Compensation Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals, which are based on relative total shareholder return, were attained for the performance period of July 3, 2022, to June 28, 2025.

Represents a grant of restricted stock that vests in three equal annual installments beginning on August 19, 2026.

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 27, 2025.

The price reported in Column 4 is a weighted average price of all shares sold. The shares were sold in multiple transactions at prices ranging in price from $98.86 to $99.84. The reporting person undertakes to provide to Performance Food Group Company, any security holder of Performance Food Group Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price of all shares sold. The shares were sold in multiple transactions at prices ranging in price from $99.86 to $99.95. The reporting person undertakes to provide to Performance Food Group Company, any security holder of Performance Food Group Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Executive Vice President and Chief Human Resources Officer


Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

Includes 131,092 RSUs.


The shares of common stock were withheld by the Company in order to pay tax withholding obligations in connection with the vesting of RSUs.

/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah


The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.


Represents a grant of restricted stock that vests on August 19, 2026.

Executive Vice President and Chief Development Officer


The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $5.06, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.96, inclusive.


The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 28, 2025.

The price reported in Column 4 is a weighted average price of all shares sold. The shares were sold in multiple transactions at prices ranging in price from $98.90 to $99.89. The reporting person undertakes to provide to Performance Food Group Company, any security holder of Performance Food Group Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price of all shares sold. The shares were sold in multiple transactions at prices ranging in price from $99.92 to $99.95. The reporting person undertakes to provide to Performance Food Group Company, any security holder of Performance Food Group Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Executive Vice President and Chief Information Officer


Senior Vice President and Chief Accounting Officer


Executive Vice President and Chief Financial Officer


Executive Vice President, General Counsel and Corporate Secretary


By: Brooke R. Phillips For: Joseph L. Moskowitz


Includes 49,138 RSUs.


Includes shares acquired through dividend reinvestment plan


Pursuant to the Issuer's previously announced stock buyback program, the Issuer entered into a Share Repurchase Agreement with PJAM IBP Holdings, Inc. ("PJAM") for the purchase of 200,000 shares of its common stock in a privately-negotiated transaction for an aggregate purchase price of $51,476,000. The repurchase was approved by the company's board of directors and is exempt from Section 16(b) by the virtue of Rule 16b-3(e). IBP Holding Company is the sole shareholder of PJAM.

These securities are held directly by PJAM.  The Reporting Persons, other than PJAM, disclaim beneficial ownership in the reported securities except to the extent of his or its pecuniary interest therein.

These securities are held directly by Installed Building Systems, Inc.  The Reporting Persons, other than Installed Building Systems, Inc., disclaim beneficial ownership in the reported securities except to the extent of his or its pecuniary interest therein.

These securities are held by a trust for the benefit of one of Mr. Edwards' children. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein.


Common Stock

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The option is fully vested and exercisable.

/s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer


The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of RSUs.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.665 to $14.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Common Stock

Includes 126,904 shares of common stock, par value $0.0001 per share ("Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on May 19, 2025 pursuant to the Issuer's 2023 Incentive Plan. The RSUs will vest in full, and an equal number of shares of Common Stock will be deliverable to the reporting person, immediately prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service through such vesting date.

Represents shares of Common Stock that were withheld to cover the tax withholding obligations in connection with the exercise and settlement of stock options that were set to expire on August 26, 2025.

The stock option was fully exercisable on April 30, 2019.

/s/ Bill Roeschlein, as attorney-in-fact


Withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

/s/ Eryk J. Spytek by Power of Attorney from Sylvia Wilks


Class B Common Stock and Limited Partnership Interests

Class A Common Stock

Class A Common Stock

Class A Common Stock

On August 18, 2025, pursuant to the terms of an exchange agreement, dated as of July 22, 2021 (as amended, the "Exchange Agreement"), 100,000 shares of Class B common stock of the Issuer ("Class B common stock") and limited partnership interests of Core & Main Holdings, LP (together, a "Paired Interest") were exchanged for shares of Class A common stock of the Issuer ("Class A common stock"), on a one-for-one basis.

On August 18, 2025, pursuant to the terms of the Fourth Amended and Restated LLC Agreement of Core & Main Management Feeder, LLC ("Management Feeder"), dated as of February 13, 2024 (as amended, the "LLC Agreement"), 100,000 vested common units ("Units") held directly by the reporting person were redeemed at the discretion of the reporting person for 100,000 Paired Interests.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 17, 2025.

The price reported represents the weighted average price of shares of Class A common stock sold in multiple transactions at prices ranging from $63.8250 to $64.7650 per share. The reporting person will provide to the Issuer, or the Securities and Exchange Commission staff, upon request, information regarding the number of shares sold at each price within the range.

Pursuant to the terms of the Exchange Agreement, Paired Interests are exchangeable at the discretion of the reporting person for shares of Class A common stock on a one-for-one basis or, at the election of a majority of the disinterested members of the Issuer's board of directors, for cash from a substantially concurrent public offering or private sale (based on the price of Class A common stock sold in such public offering or private sale, net of any underwriting discounts and commissions, for each limited partnership interest exchanged, subject to certain exceptions, conditions and adjustments). The Class B common stock and limited partnership interests have no expiration date.

Represents securities held by Management Feeder in respect of Units directly held by the reporting person. Pursuant to the LLC Agreement, such vested Units held by the reporting person are redeemable at the discretion of the reporting person for Paired Interests, on a one-for-one basis.

/s/ Mark Whittenburg, as Attorney-in-Fact for Mark R. Witkowski


Common Stock, par value $0.001 per share

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.675 to $7.760, inclusive. The reporting person undertakes to provide to N-able, Inc., any security holder of N-able, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

/s/ Kate Salley, Attorney-in-Fact for Michael Adler


Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.

The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $45.28 to $47.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Held by The Shawn M. Soderberg 2005 Trust, of which the Reporting Person is the trustee.

Chief Legal Officer and Corporate Secretary


Class B Common Stock

Class A Common Stock

Each share of Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis at the option of the Reporting Person. In addition, each share of Class B Common Stock will convert automatically into Class A Common Stock on a one-for-one basis upon any transfer of such share, except for certain permitted transfers described in the Issuer's Amended and Restated Certificate of Incorporation. Shares of Class B Common Stock do not expire.

On August 18, 2025, the Reporting Person directed the sale of 357,812 shares of Class B Common Stock as part of the Issuer's secondary offering, resulting in the automatic conversion of the shares into Class A Common Stock upon execution of the sale.

Represents shares of Class A common stock sold by the Reporting Person as part of a secondary offering of the Issuer's shares.

Represents shares of Class A common stock held through an irrevocable non-grantor trust, of which the Reporting Person's legal counsel is the sole trustee and the Reporting Person's child is the beneficiary. The Reporting Person disclaims beneficial ownership of the shares of Class A common stock.

Represents shares of Class B common stock held through an irrevocable grantor trust, of which the Reporting Person is the sole trustee and the Reporting Person is a beneficiary. The Reporting Person is entitled to annuity payments from the trust, with any remaining assets to be distributed to the Allaire 2025 GRAT Remainder Trust, of which the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of the shares of Class B common stock except to the extent of his pecuniary interest therein.

/s/ Sarah K. Wilson, as Attorney-in-Fact for Jeremy Allaire


Silversmith Partners I GP, LLC is the general partner of Silversmith Partners I GP, L.P., which is the general partner of Silversmith Capital Partners I-A, L.P., Silversmith Capital Partners I-B, L.P. and Silversmith Capital Partners I-C, L.P. (collectively, the "Silversmith Entities"). Silversmith Capital Partners I-A, L.P. holds 9,855,844 shares of common stock of the Issuer, Silversmith Capital Partners I-B, L.P. holds 3,565,133 shares of common stock of the Issuer, and Silversmith Capital Partners I-C, L.P. holds 903,220 shares of common stock of the Issuer.

Each Reporting Person disclaims beneficial ownership of all of the securities that are or may be beneficially owned by the Silversmith Entities or any of their affiliates, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Silversmith Capital Partners I-A, L.P., Silversmith Capital Partners I-B, L.P. and Silversmith Capital Partners I-C, L.P. have entered into a Stockholders Agreement with certain persons who are owners of more than 10% of the Issuer's outstanding common stock and, as a result, the Silversmith Entities may be deemed a member of a "group" (as such term is used under Section 13(d) of the Securities Exchange Act of 1934, as amended) with such persons.


These grants shall vest as follows: (i) 500,000 shares shall vest upon the Issuer achieving a market capitalization of $150,000,000 and (ii) 500,000 shares shall vest upon the Issuer achieving a market capitalization of $500,000,000.


The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 13, 2024.

/s/ Philip Reuther, as attorney-in-fact for Howard Wenger


Represents 17,557 shares of Class A common stock held outright by the Reporting Person and 12,320 shares of Class A common stock subject issuable upon the vesting of restricted stock units.

Sarah Wilson, as Attorney-in-Fact for Craig W. Broderick


Represents restricted stock units ("RSUs") that vest as follows: (1) 25,000 RSUs shall vest on December 15, 2025; (2) 12,500 RSUs shall vest on May 26, 2026; and (3) 12,500 RSUs shall vest on August 16, 2026; provided, however, that such awards shall vest immediately in full upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.72, inclusive. The reporting person undertakes to provide to N-able, Inc., any security holder of N-able, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

/s/ Kate Salley, Attorney-in-Fact for Ann S. Johnson


Represents 21,892 shares of Class A common stock held outright by the Reporting Person and 7,060 shares of Class A common stock issuable upon the vesting of restricted stock units.

Sarah Wilson, as Attorney-in-Fact for Danita K. Ostling


By: /s/ Melissa Jackmin, Attorney-in-fact For: Bernard Thiers


Represents 5,148,494 shares sold by Summit Partners Growth Equity Fund IX-A, L.P., 3,214,648 shares sold by Summit Partners Growth Equity Fund IX-B, L.P., 35,938 shares sold by Summit Investors GE IX/VC IV, LLC, 4,804 shares sold by Summit Partners Entrepreneur Advisors Fund II, L.P. and 3,759 shares sold by Summit Investors GE IX/VC IV (UK), L.P.

The reported securities are held as follows: 20,529,149 shares in the name of Summit Partners Growth Equity Fund IX-A, L.P.; 12,818,117 shares in the name of Summit Partners Growth Equity Fund IX-B, L.P.; 143,301 shares in the name of Summit Investors GE IX/VC IV, LLC; 19,157 shares in the name of Summit Partners Entrepreneur Advisors Fund II, L.P.; and 14,991 shares in the name of Summit Investors GE IX/ VC IV (UK), L.P.

Darren Black is a Managing Director and Member of Summit Master Company, LLC, the general partner of Summit Partners, L.P. Summit Partners, L.P. is the managing member of Summit Partners GE IX, LLC, which is general partner of Summit Partners GE IX, LP, which is the general partner of Summit Partners Growth Equity Fund IX-A, L.P. and Summit Partners Growth Equity Fund IX-B, L.P. Summit Master Company, LLC is (i) the sole member of Summit Partners Entrepreneur Advisors GP II, LLC, which is the general partner of Summit Partners Entrepreneur Advisors Fund II, L.P. and (ii) the managing member of Summit Investors Management, LLC, which is the manager of Summit Investors GE IX/VC IV, LLC, and the general partner of Summit Investors GE IX/VC IV (UK), L.P.

Summit Master Company, LLC, as the sole member of Summit Partners Entrepreneur Advisors GP II, LLC and the managing member of Summit Investors Management, LLC, has delegated investment decisions, including voting and dispositive power, to Summit Partners, L.P. and its investment committee responsible for voting and investment decisions with respect to LifeStance Health Group, Inc. Summit Partners, L.P., through a four person investment committee, currently composed of Peter Y. Chung, Mark A. deLaar, Darren M. Black and Craig D. Frances, has voting and dispositive authority over the shares held by each of these entities and therefore beneficially owns such shares. Each of the Summit Funds, Mr. Chung, Mr. deLaar, Mr. Black and Dr. Frances disclaim beneficial ownership of the shares, except, in each case, to the extent of such person's or entity's pecuniary interest therein.

/s/ Ryan Pardo, as Attorney-in-Fact for Darren M. Black


Common Stock

Common Stock

Represents the weighted average of a range of sale prices from $87.92 to $88.89. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company, or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.

Received as employment compensation

/s/ Ryan Hicke by Diane Gallagher, attorney in fact


The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.02 to $128.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

By: /s/ Melissa Jackmin, Attorney-in-fact For: Rodney David Patton


Represents shares of Class A common stock sold by the Reporting Person as part of a secondary offering of the Issuer's shares.

Represents 308,170 shares of Class A common stock held outright by the Reporting Person and 7,060 shares of Class A common stock issuable upon the vesting of restricted stock units.

Sarah Wilson, as Attorney-in-Fact for M. Michele Burns


These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.

This transaction was executed in multiple trades at prices ranging from $27.03 to $27.61. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Certain of these securities are restricted stock units. Each restricted stock unit represents the Reporting Person's right to receive one share of Class A Common Stock, subject to the applicable vesting schedule through February 15, 2029. In the event the Reporting Person ceases to be a Service Provider, the unvested restricted stock awards and restricted stock units will be cancelled by the Issuer.


Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs vest 100% as of the last business day preceding the date of the Issuer's next scheduled annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date and acceleration in certain circumstances.

/s/ Philip Reuther, Attorney-in-Fact for Mark Menezes


Class A Common Stock

Class A Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock.

The RSUs vested on the day immediately preceding the date of the first annual meeting of stockholders of the Issuer following the date of grant and were settled on the transaction date reported herein.

The RSUs vested upon the appointment of Ms. Vanzura as the permanent Chief Marketing Officer and were settled on the transaction date reported herein.

On July 8, 2025, the issuer effected a 1-for-40 reverse stock split of the issuer's Class A common stock and Class B common stock, resulting in proportionate adjustments to the number of shares of Class A common stock beneficially owned by the reporting person, including shares underlying outstanding RSUs. Accordingly, the securities reported on this Form 4 have been adjusted to reflect the 1-for-40 reverse stock split.

/s/ Chris Blevins, Attorney-In-Fact for Elisabeth Vanzura


Common Shares

34% of the options vested on the grant date and the remainder will vest in equal installments on each anniversary of the grant date until August 18, 2027.


/s/ Philip Reuther, Attorney-in-Fact for Willy C. Shih


CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


Class A Common Stock

Represents the number of shares withheld to cover tax withholding obligations in connection with the vesting of RSUs.

11 RSUs vested on May 24, 2025 and were settled on the transaction date herein. The remaining unvested RSUs will vest in three approximately equal quarterly installments.


Common Shares


The restricted stock units (the "RSUs") granted to the Reporting Person on August 7, 2025 (the "Effective Date") are issued pursuant to the Verb Technology Company, Inc. 2019 Stock Incentive Plan, as amended. The RSUs will vest on the one-year anniversary of the Effective Date.


Represents 60,145 shares of Class A common stock held outright by the Reporting person and 545,725 shares of Class A common stock issuable upon the vesting of restricted stock units.

/s/ Sarah K. Wilson, as Attorney-in-Fact for Heath Tarbert


Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Live Oak Bancshares, Inc. (the "Company") voting common stock.

2,420 of the RSUs will vest on each of August 19, 2025, 2026, 2027, 2028, and 2029, subject to the reporting person's continuous service to the Company or a related entity on such date.

943 of the RSUs vested on December 9, 2024 and 943 of the RSUs will vest on each of December 8, 2025, 2026, and 2027, subject to the reporting person's continuous service to the Company or a related entity on such date.

945 of the RSUs vested on December 9, 2024, and 946 of the RSUs will vest on each of December 8, 2025, 2026, 2027, and 2028, subject to the reporting person's continuous service to the Company or a related entity on such date.

235 of the RSUs will vest on each of December 15, 2024 and 2025, and 236 of the RSUs will vest on December 15, 2026, subject to the reporting person's continuous service to the Company or a related entity on such date.

145 of the RSUs will vest on each of February 22, 2025 and 2026, subject to the reporting person's continuous service to the Company or a related entity on such date.

The RSUs vest in five equal annual installments beginning on February 10, 2026, subject to the reporting person's continuous service to the Company or a related entity on such date.

/s/ Jonathan A. Greene, By Power of Attorney


Represents the estimated number of share equivalents held by the reporting person in the unitized stock fund included in the Ameren Corporation Savings Investment Plan as of July 31, 2025.

Amount includes 126 accrued dividend equivalents acquired during the first and second quarters of 2025  pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2022 Omnibus Incentive Compensation Plan.

Jonathan T. Shade, Deputy Corp. Secy. for Ameren Corporation, attorney-in-fact for Shawn E. Schukar


Class A Common Stock

Class A Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock.

The RSUs vested on the day immediately preceding the date of the first annual meeting of stockholders of the Issuer following the date of grant and were settled on the transaction date reported herein.

The RSUs vested upon the appointment of a permanent President and Chief Executive Officer and were settled on the transaction date reported herein.

/s/ Chris Blevins, Attorney-in-Fact for John Larson


Class B Common Stock

Class A Common Stock

Each share of Class B common stock is convertible into Class A common stock on a one-for-one basis at the option of the Reporting Person. In addition, each share of Class B common stock will convert automatically into Class A common stock on a one-for-one basis upon any transfer of such share, except for certain permitted transfers described in the Issuer's Amended and Restated Certificate of Incorporation. Shares of Class B common stock do not expire.

On August 18, 2025, the Reporting Person directed the sale of 260,374 shares of Class B common stock as part of the Issuer's secondary offering, resulting in the automatic conversion of the shares into Class A common stock upon execution of the sale.

Represents shares of Class A common stock sold by the Reporting Person as part of a secondary offering of the Issuer's shares.

Represents shares of Class A common stock held through an irrevocable grantor trust, of which the Reporting Person's wife, daughter and brother-in-law are trustees and the Reporting Person's
child is the beneficiary. The Reporting Person disclaims beneficial ownership of the shares of Class A common stock.

Represents shares of Class B Common stock held through an irrevocable grantor trust, of which the Reporting Person is the sole trustee and the Reporting Person is a beneficiary. The Reporting Person is entitled to annuity payments from the trust, with any remaining assets to be distributed to the Calico Trust, of which the Reporting Person's child is the beneficiary. The Reporting Person disclaims beneficial ownership of the shares of Class B common stock except to the extent of his pecuniary interest therein.

Sarah Wilson, as Attorney-in-Fact for Patrick Sean Neville


Common Stock

Common Stock

Common Stock

Delivery of shares of the company's common stock was made to the reporting person without the payment of any consideration in connection with the vesting of the underlying restricted stock units that were awarded as compensation.

The restricted stock units were awarded as compensation and converted to common stock on a 1 to 1 basis upon the vesting date.

The performance stock units were awarded as compensation and converted to common stock based on the achievement of certain performance factors.

The options vest based on conditions set forth in their respective agreements.

Executive Vice President, Chief Human Resources Officer


Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs vest 100% as of the last business day preceding the date of the Issuer's next scheduled annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date and acceleration in certain circumstances.

/s/ Philip Reuther, Attorney-in-Fact for Monica Karuturi


/s/ Philip Reuther, Attorney-in-Fact for Jeffrey Guldner


The shares were sold in multiple trades at prices ranging from $89.75 to $89.90. The price reported above reflects the weighted average sales price.

The shares were sold in multiple trades at prices ranging from $88.74 to $89.39. The price reported above reflects the weighted average sales price.

/s/ Jeanne A. Thoma, by attorney-in-fact Meredith W. Cook


Ordinary Shares - Restricted Stock Units

Ordinary Shares

Ordinary Shares

Ordinary Shares

End-of-period holdings include monthly purchases under the nVent Electric plc Employee Stock Purchase Plan (ESPP) in exempt transactions pursuant to Rule 16b-3(c).

Shares swapped to cover the stock option exercise prices resulting from the stock option exercises.

End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).

Shares of nVent Electric plc will be delivered to the reporting person in accordance with their irrevocable deferral election.

This option is presently exercisable in full.

/s/ John K. Wilson, Attorney-in-Fact for Beth A. Wozniak


The shares were sold in multiple trades at prices ranging from $89.27 to $90.18. The price reported above reflects the weighted average sales price.

/s/ Antonio R. Pera, by attorney-in-fact Meredith W. Cook


Shares are compensation for director fees in lieu of cash and are fully vested. The Reporting Person has dividend and voting rights on all these shares.

Donald Klimoski II, on behalf of William C. Zachary, by power of attorney dated Dcember 14, 2017


Represents shares of Class A common stock sold by the Reporting Person as part of a secondary offering of the Issuer's shares.

Represents 299,875 shares of Class A common stock issuable upon the vesting of restricted stock units.

/s/ Sarah K. Wilson, as Attorney-in-Fact for Jeremy Fox-Geen


/s/ Shayon T. Smith, Agent for Natalie Schechtman


Common Stock

Each restricted stock unit represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting.

Grant vests over 4 years with 25% of the shares vesting on August 15, 2026 then the remaining shares vesting quarterly thereafter until fully vested.

Justin Scarpulla by Blair Walters as Attorney-in-Fact


/s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode


By Fenway Summer Charitable Remainder Trust

Represents shares of Class A common stock sold by the Reporting Person and its affiliated entities as part of a secondary offering of the Issuer's shares.

Represents 216,022 shares of Class A common stock held outright by the Reporting Person and 7,060 shares of Class A common stock issuable upon the vesting of restricted stock units.

The Reporting Person is the Managing Member of FS Venture Capital LLC, and the Managing Member of Fenway Summer Investment Management LLC, which is the Manager of Fenway Summer Ventures LP. The Reporting Person has controlling voting and dispositive power with regard to the shares of Class A Common Stock held by such entities. The Reporting Person disclaims beneficial ownership of the shares Class A Common Stock except to the extent of his pecuniary interest therein.

The Reporting Person is the sole trustee of the Fenway Summer Charitable Remainder Trust and the American Heart Association and the John F. Kennedy Memorial Center for the Performing Arts are the beneficiaries. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Sarah Wilson, as Attorney-in-Fact for Rajeev V. Date


These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.77 to $29.40 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

/s/ Allison Hoffman by Power of Attorney for David Linetsky


Kiniksa Pharmaceuticals International, plc

Class A Ordinary Share

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $33.41 and $34.405. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

The option is fully vested and exercisable.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.

This transaction was executed in multiple trades at prices ranging from $19.75 to $20.715. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.


Represents a grant of time-vesting restricted stock, which will vest on January 14, 2028.

/s/Robert L. Holladay, Jr., on behalf of Keira L. Lombardo, pursuant to a power of attorney


Represents shares of Class A common stock sold by the Reporting Person as part of a secondary offering of the Issuer's shares.

Represents 117,758 shares of Class A common stock held outright by the Reporting Person and 413,045 shares of Class A common stock issuable upon the vesting of restricted stock units.

/s/ Sarah K. Wilson, as Attorney-in-Fact for Nikhil Chandhok


The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted May 16, 2025.

Shares held following the reported transaction include 258,855 restricted stock units, which are subject to forfeiture until they vest.


The sale reported on this Form 4 represents shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 10/3/2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.3300 to $24.3700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

/s/ Margaret Chow, by Power of Attorney for Matthew M. Cain


Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs vest 100% as of the last business day preceding the date of the Issuer's next scheduled annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date and acceleration in certain circumstances.

/s/ Philip Reuther, Attorney-in-Fact for Julia Blunden


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $254.64 to $256.72. The reporting person undertakes to
provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price
within the range set forth on this footnote.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $254.45 to $258.42. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth on this footnote.

/s/ Frederick Williams, Attorney-in-Fact


Shares held by the Denise P. Watkins u/a/d 01-0701994 William D. Watkins Trustee of Watkins Family Trust, of which the Reporting Person and his spouse are co-trustees and co-beneficiaries.

/s/ Philip Reuther, Attorney-in-Fact for William D. Watkins


Represents 14,179 shares of Class A common stock held outright by the reporting person and 79,430 shares of Class A common stock issuable upon the vesting of restricted stock units.

/s/ Sarah K. Wilson, as Attorney-in-Fact for Tamara Schulz


Represents 5,148,494 shares sold by Summit Partners Growth Equity Fund IX-A, L.P., 3,214,648 shares sold by Summit Partners Growth Equity Fund IX-B, L.P., 35,938 shares sold by Summit Investors GE IX/VC IV, LLC, 4,804 shares sold by Summit Partners Entrepreneur Advisors Fund II, L.P. and 3,759 shares sold by Summit Investors GE IX/VC IV (UK), L.P.

The reported securities are held as follows: 20,529,149 shares in the name of Summit Partners Growth Equity Fund IX-A, L.P.; 12,818,117 shares in the name of Summit Partners Growth Equity Fund IX-B, L.P.; 143,301 shares in the name of Summit Investors GE IX/VC IV, LLC; 19,157 shares in the name of Summit Partners Entrepreneur Advisors Fund II, L.P.; and 14,991 shares in the name of Summit Investors GE IX/ VC IV (UK), L.P.

Summit Partners, L.P. is the managing member of Summit Partners GE IX, LLC, which is general partner of Summit Partners GE IX, L.P., which is the general partner of Summit Partners Growth Equity Fund IX-A, L.P. and Summit Partners Growth Equity Fund IX-B, L.P. Summit Master Company, LLC is (i) the sole member of Summit Partners Entrepreneur Advisors GP II, LLC, which is the general partner of Summit Partners Entrepreneur Advisors Fund II, L.P. and (ii) the general partner of Summit Partners L.P., which is the manager of Summit Investors Management, LLC, which is the manager of Summit Investors GE IX/VC IV, LLC, and the general partner of Summit Investors GE IX/VC IV (UK), L.P.

Summit Master Company, LLC, as the sole member of Summit Partners Entrepreneur Advisors GP II, LLC and the managing member of Summit Investors Management, LLC, has delegated investment decisions, including voting and dispositive power, to Summit Partners, L.P. and its investment committee responsible for voting and investment decisions with respect to LifeStance Health Group, Inc. Summit Partners, L.P., through a four-person investment committee, currently composed of Peter Y. Chung, Mark A. deLaar, Darren M. Black and Craig D. Frances, has voting and dispositive authority over the shares held by each of these entities and therefore beneficially owns such shares. Each of the Summit Funds, Mr. Chung, Mr. deLaar, Mr. Black and Dr. Frances disclaim beneficial ownership of the shares, except, in each case, to the extent of such person's or entity's pecuniary interest therein.


Common Stock


The transactions were effectuated in order to transfer shares from the Reporting Person's brokerage account into the Reporting Person's IRA account.

/s/ Jenny B. Neslin, Attorney-in-Fact for Matthew Jozoff


/s/ Jenna Gallagher for Jose M Gutierrez


Shares withheld in payment of tax liability in connection with the vesting of reported awards of restricted stock units, which vested on August 19, 2025.

/s/ Erin Conway, Attorney-in-Fact for Mary N. Dillon


On August 19, 2025, the reporting person transferred 2,000 shares of VSE common stock to a charitable organization for no consideration.


/s/ Kathleen S. Purcell, Agent for Kirk Tanner


Common Stock, $0.001 par value per share

Represents restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of common stock of Workhorse Group Inc. (the "Company"), vesting on February 18, 2026.  Upon vesting, the RSUs may be settled in cash at the discretion of the Company's Board of Directors.

Arthur McMahon, attorney-in-fact for Richard F. Dauch


/s/ Arthur McMahon, III, attorney-in-fact for Austin S. Miller


/s/ Arthur McMahon, attorney-in fact for Raymond J. Chess


Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

Includes 85,336 shares underlying restricted stock units. Upon settlement in accordance with the terms of the applicable award agreement, the restricted stock units will be paid on a one-for-one basis in shares of the Issuer's common stock.

These shares are held in a Spousal Lifetime Access Trust ("SLAT") for the benefit of the reporting person's spouse and children. The reporting person's spouse serves as trustee of the SLAT. The reporting person disclaims beneficial ownership of the shares in the SLAT.

By: /s/ Lauren A. Hurley, as Attorney-in-Fact


/s/ Arthur McMahon, attorney-in-fact for Pamela S. Mader


/s/ Arthur McMahon, attorney-in-fact for Jean Botti


Includes 24,407 shares underlying restricted stock units. Upon settlement in accordance with the terms of the applicable award agreement, the restricted stock units will be paid on a one-for-one basis in shares of the Issuer's common stock.


/s/ Indira Sordo, Attorney-in-Fact for Vagn O. Sorensen


Includes 20,346 shares underlying restricted stock units. Upon settlement in accordance with the terms of the applicable award agreement, the restricted stock units will be paid on a one-for-one basis in shares of the Issuer's common stock.


Shares are compensation for director fees in lieu of cash and are fully vested. The Reporting Person has dividend and voting rights on all these shares.

Donald Klimoski II, on behalf of Russell E. Burke, by power of attorney dated March 27, 2018